Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Get SEC filing alerts via email and in your feed for GSK PLC

GSK GSK GLAXF

GSK PLC

Latest news & discussion for GSK PLC:

1

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 10 months ago | 0 comments

2

1

GSK PLC B7-H3 ADC US FDA Breakthrough Therapy Designation

Posted by AssetRoom | 10 months ago | 0 comments

3

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 10 months ago | 0 comments

4

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 10 months ago | 0 comments

5

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 10 months ago | 0 comments

6

1

GSK PLC FDA Expands Jemperli Approval

Posted by AssetRoom | 10 months ago | 0 comments

7

1

GSK PLC Total Voting Rights

Posted by AssetRoom | 10 months ago | 0 comments

8

1

GSK PLC 2nd Quarter Results

Posted by AssetRoom | 10 months ago | 0 comments

9

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 10 months ago | 0 comments

10

1

GSK PLC CHMP positive opinion on Arexvy for 50-59 at risk

Posted by AssetRoom | 10 months ago | 0 comments

11

1

GSK PLC Blenrep EMA Filing Acceptance

Posted by AssetRoom | 11 months ago | 0 comments

12

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 11 months ago | 0 comments

13

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 11 months ago | 0 comments

14

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 11 months ago | 0 comments

15

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 11 months ago | 0 comments

16

1

GSK PLC GSK and CureVac collaboration restructured

Posted by AssetRoom | 11 months ago | 0 comments

17

1

GSK PLC Total Voting Rights

Posted by AssetRoom | 11 months ago | 0 comments

18

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 12 months ago | 0 comments

19

1

GSK PLC Omjjara approved in Japan for myelofibrosis

Posted by AssetRoom | 12 months ago | 0 comments

20

1

GSK PLC EMA validates Jemperli marketing authorisation

Posted by AssetRoom | 12 months ago | 0 comments

21

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 12 months ago | 0 comments

22

1

GSK PLC Director/PDMR Shareholding

Posted by AssetRoom | 12 months ago | 0 comments

23

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 12 months ago | 0 comments

24

1

GSK PLC Statement: Zantac (ranitidine) litigation

Posted by AssetRoom | 12 months ago | 0 comments

25

1

GSK PLC FDA approves Arexvy for adults 50-59 at risk

Posted by AssetRoom | 12 months ago | 0 comments